Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 2, 2007, Pages

  Junaid, Asad ^a,b,c   Moon, Michael C ^a,b   Harding, Gregory E J ^a,b   Zahradka, Peter ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^c Grace Hospital Winnipeg   (Canada)

Author keywords

Cell cycle; Nuclear; Spindle

Indexed keywords

APHIDICOLIN; OSTEOPONTIN; POLO LIKE KINASE 1;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIVISION; CELL NUCLEUS; CENTROSOME; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

APHIDICOLIN; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELL NUCLEUS; DNA-DIRECTED DNA POLYMERASE; HUMANS; IMMUNOPRECIPITATION; MUTATION; OSTEOPONTIN; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 33847080006     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00477.2006     Document Type: Article

References (34)

1. Aitken CJ, Hodge JM, Nicholson GC. Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro. J Cell Biochem 93: 896-903, 2004.
2. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 98: 2218-2227, 1996.
3. Bourassa B, Monaghan S, Rittling SR. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice. Cell Immunol 227: 1-11, 2004.
4. Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30-31: 92-102, 1998.
5. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107: 1055-1061, 2001.
6. Devoll RE, Li W, Woods KV, Pinero GJ, Butler WT, Farach-Carson MC, Happonen RP. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity. J Oral Pathol Med 28: 97-101, 1999.
7. Eleftheriou A, Yoshida M, Henderson BR. Nuclear export of human β-catenin can occur independent of CRM1 and the adenomatous polyposis coli tumor suppressor. J Biol Chem 276: 25883-25888, 2001.
8. Elgavish A, Prince C, Chang PL, Lloyd K, Lindsey R, Reed R. Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro. Prostate 35: 83-94, 1998.
9. Franzen A, Heinegard D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 232: 715-724, 1985.
10. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 13: 120-125, 1993.
11. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 19: 615-622, 2000.
12. Glover DM, Hagan IM, Tavares AA. Polo-like kinases: a team that plays throughout mitosis. Genes Dev 12: 3777-3787, 1998.
13. Hagting A, Karlsson C, Clute P, Jackman M, Pines J. MPF localization is controlled by nuclear export. EMBO J 17: 4127-4138, 1998.
14. Ishizeki K, Nomura S, Takigawa M, Shioji H, Nawa T. Expression of osteopontin in Meckel's cartilage cells during phenotypic transdifferentiation in vitro, as detected by in situ hybridization and immunocytochemical analysis. Histochem Cell Biol 110: 457-466, 1998.
15. Jin J, Woodgett JR. Chronic activation of protein kinase Bβ/Akt2 leads to multinucleation and cell fusion in human epithelial kidney cells: events associated with tumorigenesis. Oncogene 24: 5459-5470, 2005.
16. Lekic P, Sodek J, McCulloch CA. Relationship of cellular proliferation to expression of osteopontin and bone sialoprotein in regenerating rat periodontium. Cell Tissue Res 285: 491-500, 1996.
17. 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 77: 665-672, 1995.
18. Philip S, Bulbule A, Kundu GC. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 276: 44926-44935, 2001.
19. Reinhardt A, Hubbard T. Using neural networks for prediction of the subcellular location of proteins. Nucleic Acids Res 26: 2230-2236, 1998.
20. Sodhi CP, Phadke SA, Batlle D, Sahai A. Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin. Am J Physiol Renal Physiol 280: F667-F674, 2001.
21. Somers KD, Murphey MM. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells. Cancer Res 40: 4410-4414, 1980.
22. Sterling H, Saginario C, Vignery A. CD44 occupancy prevents macrophage multinucleation. J Cell Biol 143: 837-847, 1998.
23. Takahashi F, Takahashi K, Okazaki T, Maeda K, Ienaga H, Maeda M, Kon S, Uede T, Fukuchi Y. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 24: 264-271, 2001.
24. Thyberg J, Hultgardh-Nilsson A, Kallin B. Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta. Differentiation 59: 243-252, 1995.
25. Tuck AB, Arsenault DM, O'Malley FP, Hota C, Ling MC, Wilson SM, Chambers AF. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 18: 4237-4246, 1999.
26. Tuck AB, O'Malley FP, Singhal H, Tonkin KS, Harris JF, Bautista D, Chambers AF. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch Pathol Lab Med 121: 578-584, 1997.
27. Verstrepen WA, Persy VP, Verhulst A, Dauwe S, De Broe ME. Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat. Nephrol Dial Transplant 16: 712-724, 2001.
28. Weintraub AS, Schnapp LM, Lin X, Taubman MB. Osteopontin deficiency in rat vascular smooth muscle cells is associated with an inability to adhere to collagen and increased apoptosis. Lab Invest 80: 1603-1615, 2000.
29. Xie Y, Nishi S, Iguchi S, Imai N, Sakatsume M, Saito A, Ikegame M, Iino N, Shimada H, Ueno M, Kawashima H, Arakawa M, Gejyo F. Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process. Kidney Int 59: 959-974, 2001.
30. 2 stimulates vascular smooth muscle cell proliferation via the EP2 receptor. Mol Cell Endocrinol 203: 77-90, 2003.
31. Zahradka P, Litchie B, Storie B, Helwer G. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase. Endocrinology 145: 2978-2987, 2004.
32. Zhou T, Aumais JP, Liu X, Yu-Lee LY, Erikson RL. A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell 5: 127-138, 2003.
33. Zohar R, Lee W, Arora P, Cheifetz S, McCulloch C, Sodek J. Single cell analysis of intracellular osteopontin in osteogenic cultures of fetal rat calvarial cells. J Cell Physiol 170: 88-100, 1997.
34. Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184: 118-130, 2000.